You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 10, October 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  COMMENTARY
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

The Diagnosis and Treatment of Gastroesophageal Reflux Disease in a Managed Care Environment

A Surgeon's Response

Peter F. Crookes, MD; Tom R. DeMeester, MD

Arch Surg. 1996;131(10):1021-1023.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

GASTROESOPHAGEAL reflux disease (GERD) is one of the most common ailments in contemporary western society. Not only does it generate large spendings on over-the-counter medications, but it makes heavy demands on health care resources for diagnosis and treatment. The recent consensus document published in the Annals of Internal Medicine on March 11, 1996, 1 aims to summarize the views of a diverse group of experts about the optimal management of this common condition faced by the constraints imposed by the prevailing climate of managed care. The restrictions imposed by this fiscal environment include limitations in access to appropriate specialists, expensive testing for diagnostic and monitoring purposes, and long-term medications. More patients will have to be managed by their primary care physician on purely clinical grounds. The consensus document makes the important point that such restrictions tend to focus on short-term measures of outcome to determine if reducing expenditure on expensive testing and . . . [Full Text PDF of this Article]


Author Affiliations

Los Angeles, Calif



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.